FdaApplication
ANDA 216212
Identifiers
- fda_app_no: ANDA216212
Properties
| Property | Value |
|---|---|
| applicant_name | CADILA PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2022-11-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL |
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL |
2 products